These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 13964464)

  • 1. [Prostatic cancer in men over 65].
    de JAGER ; WASSINK WF
    Jaarb K Ned Bot Ver; 1961; 11():93-7. PubMed ID: 13964464
    [No Abstract]   [Full Text] [Related]  

  • 2. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
    Silverman JM; Krebs TL
    AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostatic carcinoma. Incidence and significance of stage I - preclinical carcinoma].
    Schmassmann A; Mihatsch MJ
    Urologe A; 1983 Sep; 22 Suppl():388-92. PubMed ID: 6685389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG; Carvahal GF; Mager DE; Haberer B; Catalona WJ
    J Urol; 1999 Nov; 162(5):1587-90. PubMed ID: 10524873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.
    Carter HB; Morrell CH; Pearson JD; Brant LJ; Plato CC; Metter EJ; Chan DW; Fozard JL; Walsh PC
    Cancer Res; 1992 Jun; 52(12):3323-8. PubMed ID: 1375867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a 5-year screening for prostatic cancer].
    Matveev BP; Komarova LE; Bukharkin BV; Sholokhov VN; Kadagidze ZG; Cheban NL; Lepédatu PI; Shelepova VM; Perederiĭ NV; Lomakin NN
    Urologiia; 2003; (1):6-10. PubMed ID: 12621958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.
    Catalona WJ; Smith DS; Ratliff TL; Dodds KM; Coplen DE; Yuan JJ; Petros JA; Andriole GL
    N Engl J Med; 1991 Apr; 324(17):1156-61. PubMed ID: 1707140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benign prostatic hypertrophy and prostate cancer].
    Mourey L; Doumerc N; Gaudin C; Gérard S; Balardy L
    Soins Gerontol; 2014; (109):28-32. PubMed ID: 25373266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First year of mass screening for prostatic cancer in Yaizu city.
    Kawabe K; Ishikawa A
    Aktuelle Urol; 2003 Jul; 34(4):242-3. PubMed ID: 14566673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.
    Punglia RS; D'Amico AV; Catalona WJ; Roehl KA; Kuntz KM
    Cancer; 2006 Apr; 106(7):1507-13. PubMed ID: 16518812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary factors and prostatic cancer.
    Bravo MP; Castellanos E; del Rey Calero J
    Urol Int; 1991; 46(2):163-6. PubMed ID: 2053225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental prostate cancer in Asian men: high prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy.
    Yang X; Monn MF; Liu L; Liu Y; Su J; Lyu T; Gong Y; Wang L; Davidson DD; Cheng L
    Prostate; 2015 Jun; 75(8):845-54. PubMed ID: 25704311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased secretion of prolactin after inhibition of dopaminergic receptors by metoclopramide in patients with cancer of the prostate].
    Baranowska B; Jeske W; Szymanowski J; Piechna K
    J Urol (Paris); 1983; 89(8):601-5. PubMed ID: 6203986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.
    Rhoden EL; Morgentaler A
    J Urol; 2003 Dec; 170(6 Pt 1):2348-51. PubMed ID: 14634413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent prostatic carcinomas found at autopsy in men over 90 years old.
    Takahashi S; Shirai T; Hasegawa R; Imaida K; Ito N
    Jpn J Clin Oncol; 1992 Apr; 22(2):117-21. PubMed ID: 1377758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district.
    Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.
    de Jong FH; Oishi K; Hayes RB; Bogdanowicz JF; Raatgever JW; van der Maas PJ; Yoshida O; Schroeder FH
    Cancer Res; 1991 Jul; 51(13):3445-50. PubMed ID: 1711411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide).
    Kuhn JM; Billebaud T; Navratil H; Moulonguet A; Fiet J; Grise P; Louis JF; Costa P; Husson JM; Dahan R
    N Engl J Med; 1989 Aug; 321(7):413-8. PubMed ID: 2503723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional electrophoretic analysis of human prostatic fluid proteins.
    Guevara J; Herbert BH; Lee C
    Cancer Res; 1985 Apr; 45(4):1766-71. PubMed ID: 2579735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breast metastases from extramammary malignancies in men].
    Murakami T; Hideura S; Shimizu R; Shimizu T; Yano K; Ishihara T
    Gan No Rinsho; 1985 Dec; 31(15):1926-32. PubMed ID: 4094074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.